Healthscope (HSP)

Stock Code


Stock Exchange


Healthscope (HSP) is one of the major healthcare services provider in Australia. The Company owns and operates a portfolio of around 45 medical/surgical, rehabilitation and psychiatric hospitals. Healthscope is also engaged in the provision of pathology services across Australia, New Zealand, Singapore and Malaysia. Healthscope listed on the Australian Stock Exchange on May 4, 1994. In December 2004, Healthscope acquired Gribbles, which helped it in achieving a significant position in the pathology industry.

Healthscope Staff Headhunted

Private health care provider, Healthscope (ASX:HSP) have had competing healthcare companies attempting to headhunt staff from the company. HSP is a takeover target, with shareholders voting in favour of the $2.7 billion deal with Asia Pacific Healthcare Group, a joint-venture between US private equity firms Carlyle Group and TPG Capital – which will assume control of the company on October 12.

Healthscope Takeover Approved

Hospital operator, Healthscope (ASX:HSP) has had their takeover bid by private equity firms The Carlyle Group and TPG Capital approved by the Foreign Investment Review Board (FIRB). The takeover is valued at $2.7 billion, with 100 percent acquisition including Healthscope's private hospitals and pathology operators.

Healthscope Dividends

1 September, 2010 - 13:40

Study the dividend history for HEALTHSCOPE LIMITED. Dividends are a distribution of a company's profit to its shareholders and paid out in the form of a cash dividend. You are eligible to receive HSP dividends if you own the HEALTHSCOPE LIMITED shares on the ex-dividend date. Traders and investors must purchase the stock before the exdividend date to be entitled to the dividend. The previous owner of the shares will receive the HSP dividend if you buy the stocks on or after the ex dividend date.

Top 200 Australian Companies Best 10 Gainers

Here are the Top 200 Australian Companies top 10 stocks which gained the most percentage points of company value on the share market, the Australian Securities Exchange (ASX) this 29th week of 2010 (last week):

The Best 3 Companies of the Week

Paladin Energy, (PDN), a company which is mainly involved in the acquisition and development of uranium projects in Australia and Africa had the best performing stocks of the week in ASX100 with a gain of 10.2 percent or 38 cents closing the week at $4.08.

Healthscope Receives $1.7 Billion Worth Takeover Bid

In a recent statement, Healthscope (HSP), one of the leading Australia based healthcare service providers that owns and operates around 45 medical/surgical, rehabilitation and psychiatric hospitals declared that it has received an indicative, non-binding and confidential takeover proposal from a private equity consortium. The bid worth as much as $1.74 billion, asking for $5.50 for each Healthscope share.

Reporting Season Final Update (March 2007)

Last week, global markets stumbled following reports that China was looking to impose controls to curb its rapidly growing economy and concerns that a soft landing for the US economy may be more difficult than first thought. In the background, the Australian reporting season continued its final week, here are analyst Macquarie Research Equities (MRE) observations and thoughts. The HY December 2006 aggregate earnings reported for the market printed 1.5 percentage points below analyst expectations versus those held at the start of this reporting season.

Healthscope (HSP) Shares Tip

Healthscope (HSP) have a 12 month share price target of $6.05 and an Outperform stock recommendation from shares analyst Macquarie Research Equities (MRE). MRE also note that current political and economic trends would generally point toward sustained industry health for the foreseeable future. The stock has drifted 6 cents lower despite announcing that they will build a new 142 bed hospital in North Western Sydney at a cost of $52m. Macquarie Research Equities (MRE) estimate that the hospital will not make a contribution to earnings until FY12 even under optimistic guidelines. MRE believe this announcement is more relevant for the implications of the industry dynamics. Greenfield hospital developments have been rare since the late 1990’s, when a number of projects almost crippled hospital groups. MRE highlight Westmead Private hospital which took Alpha Healthcare to the brink of collapse. This however was later acquired by Ramsay (RHC). The most recent Greenfield project of size was the new Epworth Hospital in Melbourne which is also struggling under the weight of its fixed costs. MRE have an Outperform recommendation on HSP.

Healthscope (HSP) Stock Recommendation

Macquarie Research Equities have reiterated their Outperform recommendation for the Healthscope (HSP) stock with a 12 month share price target of $5.15. They have commented that the company result was better than expected and that their margins were better than expected. HSP achieved a 14.3 percent in underlying EBITDA margins in 2H06, which is typically a seasonally weak half in private hospital operations.

Syndicate content

Recommended Websites